Taylor Scott
The Protein Data Bank (PDB) is a vital global resource that provides access to the 3D structures of proteins, nucleic acids, and other biomolecules, serving as a cornerstone for research in structural biology, drug discovery, and molecular biology. Established in 1971, the PDB has grown exponentially over the decades, reflecting advancements in experimental techniques like X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy. As of recent data, the PDB contains over 200,000 entries, each representing a unique molecular structure determined experimentally. This vast repository not only supports scientific discovery but also highlights the accelerating pace of structural biology research, making it an indispensable tool for understanding the molecular basis of life and disease.
Explore related products
What You'll Learn
- Total PDB Entries: Current count of all experimentally determined 3D protein structures in the PDB
- Growth Over Time: Annual increase in PDB entries since its inception in 1971
- Structure Types: Distribution of entries by type (X-ray, NMR, Cryo-EM, etc.)
- Organism Representation: Number of entries from humans, bacteria, viruses, and other organisms
- Redundancy Filtering: Methods to reduce duplicate or highly similar structures in the PDB
Total PDB Entries: Current count of all experimentally determined 3D protein structures in the PDB
The Protein Data Bank (PDB) is a vital resource for the scientific community, housing a vast collection of experimentally determined 3D structures of proteins, nucleic acids, and other biomolecules. As of the most recent data, the total number of entries in the PDB continues to grow, reflecting the rapid advancements in structural biology and the increasing demand for structural data in research and drug development. To find the current count, one would typically visit the official PDB website or use their search tools, which provide up-to-date statistics on the number of entries. As of the latest available information, the PDB contains over 200,000 entries, a testament to the collective efforts of researchers worldwide.
The growth of the PDB is a dynamic process, with new structures being added regularly. These entries are the result of various experimental methods, including X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, cryo-electron microscopy (cryo-EM), and others. Each method contributes uniquely to the diversity and richness of the database, providing structures at different resolutions and under various conditions. The continuous expansion of the PDB ensures that researchers have access to a comprehensive repository of structural data, which is essential for understanding biological processes and designing new therapeutics.
To get the exact current count of total PDB entries, one can follow these steps: visit the PDB website (https://www.rcsb.org), navigate to the statistics or data section, and look for the latest summary or report. Alternatively, using the PDB’s advanced search or API can yield precise numbers, including filters for specific experimental methods, release dates, or structural categories. For instance, querying the total number of experimentally determined structures will provide the most accurate and current figure, which is crucial for publications, grant proposals, or educational purposes.
The significance of knowing the total number of PDB entries lies in its utility for benchmarking progress in structural biology and for planning research projects. With over 200,000 entries, the PDB offers a wealth of information that can be analyzed to identify trends, such as the increasing use of cryo-EM or the growing representation of membrane proteins. Researchers often rely on this data to compare their findings with existing structures, validate models, or identify gaps in structural knowledge. Thus, staying updated on the total count is not just a matter of curiosity but a practical necessity for anyone working in the field.
In summary, the total number of experimentally determined 3D protein structures in the PDB currently exceeds 200,000 entries, a figure that continues to rise as new structures are deposited. This growth is driven by advancements in experimental techniques and the global efforts of structural biologists. To obtain the most accurate and current count, researchers should consult the official PDB website or utilize its search and data retrieval tools. Understanding and tracking this number is essential for leveraging the PDB’s resources effectively and contributing to the ongoing expansion of structural biology knowledge.
Deutsche Bank's Equities Division: Size, Scope, and Market Impact
You may want to see also
Explore related products
Growth Over Time: Annual increase in PDB entries since its inception in 1971
The Protein Data Bank (PDB) has experienced significant growth since its establishment in 1971, reflecting the rapid advancements in structural biology and the increasing importance of protein structure data in research. In its early years, the PDB grew slowly, with only a handful of structures added annually. By the end of the 1970s, the total number of entries was still in the double digits, primarily due to the limited availability of technologies like X-ray crystallography and the labor-intensive nature of structure determination. Despite these challenges, the foundation was laid for what would become an exponential increase in entries over the following decades.
The 1980s marked a turning point in the PDB's growth, driven by technological improvements and increased interest in protein structures. The annual addition of entries began to rise steadily, reaching around 100 new structures per year by the late 1980s. This period also saw the introduction of NMR spectroscopy as a complementary method to X-ray crystallography, further accelerating the pace of structure determination. The growing recognition of the PDB as a critical resource for molecular biology and drug discovery also spurred contributions from researchers worldwide, setting the stage for more rapid expansion in the subsequent decades.
The 1990s witnessed a dramatic surge in PDB entries, with annual additions increasing from a few hundred to over a thousand by the end of the decade. This growth was fueled by advancements in automation, computational methods, and the Human Genome Project, which heightened interest in protein structures as key players in biological processes. The development of high-throughput techniques and the establishment of structural genomics initiatives also played a pivotal role in this acceleration. By 2000, the PDB contained over 10,000 entries, a testament to the field's progress and the increasing demand for structural data.
From the 2000s onward, the PDB's growth continued at an impressive rate, with annual increases often exceeding 5,000 new entries. This period saw the integration of cryo-electron microscopy (cryo-EM) as a powerful tool for determining protein structures, particularly for large and complex assemblies that were previously inaccessible. The rise of open-access data sharing and international collaborations further boosted contributions to the PDB. By 2020, the total number of entries surpassed 170,000, reflecting the database's transformation into a cornerstone of modern biology and its role in addressing global challenges like pandemics and drug resistance.
In recent years, the PDB's growth has shown no signs of slowing, with annual additions consistently reaching new highs. As of 2023, the database contains over 200,000 entries, encompassing a diverse array of proteins, nucleic acids, and their complexes. This growth is a direct result of ongoing technological innovations, such as artificial intelligence-driven structure prediction (e.g., AlphaFold) and improvements in experimental methods. The PDB's expansion underscores its enduring value as a resource for understanding life at the molecular level and its potential to drive future breakthroughs in medicine, biotechnology, and beyond.
Ally Bank Referral Bonuses: What You Need to Know
You may want to see also
Explore related products
Structure Types: Distribution of entries by type (X-ray, NMR, Cryo-EM, etc.)
As of the latest data, the Protein Data Bank (PDB) contains a vast and diverse collection of biomolecular structures, with the total number of entries exceeding 200,000. This extensive repository is a critical resource for researchers in structural biology, biochemistry, and related fields. When examining the distribution of entries by structure type, it becomes evident that different experimental methods contribute variably to the PDB’s holdings. The primary methods for determining these structures include X-ray crystallography, Nuclear Magnetic Resonance (NMR) spectroscopy, Cryo-Electron Microscopy (Cryo-EM), and others such as Electron Crystallography and Neutron Diffraction.
X-ray Crystallography remains the most dominant method for structure determination, accounting for the majority of entries in the PDB. This technique has been the cornerstone of structural biology since the PDB’s inception, providing high-resolution structures of proteins, nucleic acids, and their complexes. The stability and precision of X-ray crystallography make it particularly suited for determining the atomic coordinates of biomolecules. As of recent statistics, over 80% of the PDB entries are derived from X-ray crystallography, reflecting its continued prominence in the field.
NMR Spectroscopy is the second most common method, though it represents a significantly smaller portion of the PDB compared to X-ray crystallography. NMR is particularly valuable for studying proteins in solution, offering insights into dynamics and flexibility that are often lost in crystalline environments. However, the complexity and limitations of NMR, such as its difficulty in handling large proteins, have restricted its contribution to approximately 10-15% of the PDB entries. Despite this, NMR remains indispensable for certain classes of biomolecules, especially smaller proteins and intrinsically disordered regions.
Cryo-Electron Microscopy (Cryo-EM) has emerged as a rapidly growing method in structural biology, revolutionizing the study of large macromolecular complexes and membrane proteins. Over the past decade, advancements in detector technology and image processing algorithms have dramatically improved the resolution and applicability of Cryo-EM. As a result, its contribution to the PDB has increased exponentially, now accounting for around 5-10% of entries. Cryo-EM’s ability to handle larger and more complex structures, often in near-native states, has made it a complementary technique to X-ray crystallography and NMR.
Other methods, such as Electron Crystallography and Neutron Diffraction, contribute a much smaller fraction of entries to the PDB. Electron Crystallography, which involves two-dimensional crystals, is particularly useful for membrane proteins but remains a niche technique. Neutron Diffraction, while providing unique information about hydrogen positions and dynamics, is limited by the availability of neutron sources and the complexity of the experiments. Together, these methods represent less than 1% of the PDB entries but offer specialized insights that complement the more dominant techniques.
In summary, the distribution of entries in the PDB by structure type highlights the continued dominance of X-ray crystallography, the significant but smaller contributions of NMR, the rapidly growing role of Cryo-EM, and the niche applications of other methods. Understanding this distribution is essential for researchers navigating the PDB, as it reflects both historical trends and emerging technologies in structural biology. Each method brings unique strengths and limitations, collectively enriching our understanding of biomolecular structures and their functions.
The West Bank: Israel's Territory or Not?
You may want to see also
Explore related products
Organism Representation: Number of entries from humans, bacteria, viruses, and other organisms
The Protein Data Bank (PDB) is a vital resource for structural biology, housing experimentally determined structures of proteins, nucleic acids, and other biomolecules. As of recent data, the PDB contains over 200,000 entries, reflecting the rapid growth in structural genomics and the increasing sophistication of techniques like X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy. Among these entries, the distribution across different organisms provides valuable insights into research priorities and biological significance. One of the most prominent categories is human proteins, which account for a significant portion of the PDB. Human entries dominate due to their direct relevance to medical research, drug discovery, and understanding human diseases. Approximately 30-40% of all PDB entries are of human origin, highlighting the emphasis on human health in structural biology.
Bacterial proteins represent another major category in the PDB, with around 20-25% of entries derived from bacterial organisms. This is largely driven by the importance of bacteria in understanding fundamental biological processes, antibiotic resistance, and their role as model organisms in structural studies. Bacteria such as *Escherichia coli* are frequently used in protein expression systems, making their structures more accessible for experimental determination. Additionally, bacterial proteins are critical for studying infectious diseases and developing antimicrobial therapies, further contributing to their representation in the PDB.
Viruses, despite their smaller genomes and simpler structures, account for approximately 5-10% of PDB entries. Viral proteins are of particular interest due to their role in pathogenesis, vaccine development, and antiviral drug design. Structures of viral proteins, such as those from HIV, influenza, and SARS-CoV-2, have been pivotal in understanding viral mechanisms and combating pandemics. The focus on viral proteins has intensified in recent years, especially with the global impact of COVID-19, leading to a steady increase in viral entries in the PDB.
Beyond humans, bacteria, and viruses, the PDB includes structures from a diverse range of other organisms, collectively making up 20-30% of entries. These encompass eukaryotic organisms like yeast, plants, and animals, as well as archaea and other less-studied species. Yeast, for example, is a popular model organism in biology, and its proteins are well-represented due to their similarity to human proteins and their utility in functional studies. Plant proteins are also gaining attention for their role in agriculture and biotechnology, while structures from archaea provide insights into extremophile biology and early life forms.
The organism representation in the PDB reflects both scientific interest and experimental feasibility. Humans, bacteria, and viruses dominate due to their direct relevance to health and disease, while other organisms contribute to broader biological understanding. As structural biology techniques continue to advance, the PDB is likely to expand further, with a more balanced representation of diverse organisms. Researchers and stakeholders can leverage this data to address critical questions in biology, medicine, and biotechnology, making the PDB an indispensable tool for the scientific community.
Understanding the Banker's Offer Calculation in Deal or No Deal
You may want to see also
Explore related products
Redundancy Filtering: Methods to reduce duplicate or highly similar structures in the PDB
As of recent data, the Protein Data Bank (PDB) contains over 200,000 entries, representing experimentally determined structures of proteins, nucleic acids, and other biomolecules. While this vast repository is invaluable for structural biology research, it also introduces challenges related to redundancy. Many entries in the PDB are structurally highly similar or even identical, often representing minor variations of the same protein or complex. Redundancy filtering is essential to streamline analysis, reduce computational burden, and focus on structurally diverse and biologically relevant data. Below are detailed methods to address this issue.
One widely used approach for redundancy filtering is sequence-based clustering. Tools like CD-HIT or MMseqs2 group protein structures based on sequence identity thresholds, typically ranging from 30% to 90%. By selecting a representative structure from each cluster, researchers can significantly reduce redundancy while retaining structural diversity. For example, a 90% sequence identity cutoff ensures that highly similar structures are filtered out, while a 30% cutoff captures more distant homologs. This method is straightforward and computationally efficient, making it suitable for large-scale analyses.
Another effective strategy is structure-based clustering, which groups proteins based on their three-dimensional (3D) structural similarity. Tools such as PDB-Wide, PISCES, or ESMFold use algorithms like RMSD (Root Mean Square Deviation) or TM-score to compare structures. Structure-based methods are particularly useful when sequence similarity does not correlate well with structural or functional similarity. For instance, proteins with divergent sequences but conserved folds can be identified and filtered using this approach. However, structure-based clustering is more computationally intensive than sequence-based methods.
Redundancy filtering can also be guided by biological criteria, such as taxonomic diversity or functional annotations. Researchers may choose to retain structures from different species or those representing distinct functional classes, even if they are structurally similar. This approach ensures that the filtered dataset captures a broad range of biological contexts. For example, a study focusing on enzyme mechanisms might prioritize retaining structures from different enzyme families, even if they share high structural similarity.
Automated pipelines and web servers, such as the PDB Redisuality Server or PISCES, integrate multiple filtering criteria to provide user-friendly redundancy reduction. These tools allow users to specify parameters like sequence identity, resolution, or taxonomic scope, generating non-redundant datasets tailored to specific research needs. Additionally, the PDB itself provides pre-filtered datasets, such as the PDB-100 or PDB-90, which are widely used for benchmarking and large-scale analyses.
In conclusion, redundancy filtering is crucial for effectively utilizing the vast structural data in the PDB. By employing sequence-based, structure-based, or biologically guided methods, researchers can create non-redundant datasets that enhance the efficiency and relevance of their studies. As the PDB continues to grow, the development and application of robust filtering methods will remain essential for structural biology research.
Ameris Bank's Reach: Exploring the Number of Branches Nationwide
You may want to see also
Frequently asked questions
As of the latest update, the Protein Data Bank contains over 200,000 entries, with the number continually growing as new structures are deposited.
The PDB includes experimentally determined 3D structures of proteins, nucleic acids, and complex assemblies, obtained primarily through methods like X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy.
New entries are added weekly, as researchers submit their experimentally determined structures for public release, ensuring the database remains up-to-date with the latest discoveries.
